王梦玺,吴晨洁,曹培华,陈晓虎
WANG Meng-xi,WU Chen-jie,CAO Pei-hua,CHEN Xiao-hu

• 1:南京中医药大学附属医院(江苏省中医院)

摘要(Abstract)：

为系统评价中医药疗法对难治性高血压病患者的疗效及安全性,使用计算机检索中国知网、万方、维普、CBM、PubMed、Web of Science、Cochrane Library、EMbase等数据库,筛选出应用中医药疗法辅助治疗难治性高血压病的随机对照试验,采用Cochrane Handbook评价标准对纳入文献进行质量评价,运用RevMan 5.3和Stata 12.0软件进行Meta分析。最终纳入符合标准的文献11篇,包含1 023例患者,Meta分析结果显示,在标准三联降压方案基础上,联合使用中医药疗法能进一步降低难治性高血压病患者的收缩压(MD=-16.69,95%CI[-22.21,-11.16],P<0.000 01]、降低舒张压(MD=-7.51,95%CI[-8.26,-6.76],P<0.000 01)、提高降压有效率(OR=5.16,95%CI[3.01,8.84],P<0.000 01)、提高血压达标率(OR=3.01,95%CI[1.49,6.09],P=0.002)、提高临床症状有效率(OR=4.48,95%CI[2.31,8.68],P<0.000 01),但对血肌酐水平无显著影响(MD=-2.51,95%CI[-6.91,1.89],P=0.26)。结果表明,在标准三联降压方案基础上联用中医药疗法可以进一步改善难治性高血压病患者的临床疗效且具有良好的安全性,但仍需更多高质量的临床研究加以验证。
To systematically evaluate the efficacy and safety of traditional Chinese medicine in treating patients with resistant hypertension. CNKI, Wanfang, VIP, CBM, PubMed, Web of Science, Cochrane Library, EMbase and other databases were retrieved by computers to screen out the randomized controlled trial of traditional Chinese medicine in treating resistant hypertension. Cochrane Handbook was used to evaluate the quality of the included literature, RevMan 5.3 and Stata 12.0 was used for Meta-analysis. Finally, 11 literatures meeting the criteria were included, involving 1 023 patients. The results of Meta-analysis showed that the combined therapy of standard triple antihypertensive regimen with traditional Chinese medicine could further reduce systolic blood pressure of patients with resistant hypertension(MD=-16.69, 95%CI[-22.21,-11.16], P<0.000 01), reduce diastolic blood pressure(MD=-7.51, 95%CI[-8.26,-6.76], P<0.000 01), improve the effective rate of anti-hypertension(OR=5.16, 95%CI[3.01, 8.84], P<0.000 01), improve the up-to-standard rate of blood pressure(OR=3.01, 95%CI[1.49, 6.09], P=0.002), and improve the effectiveness of clinical symptoms(OR=4.48, 95%CI[2.31, 8.68], P<0.000 01), with no significant effect on creatinine level(MD=-2.51, 95%CI[-6.91, 1.89], P=0.26). The results of this study indicated that the combined therapy of standard triple antihypertensive regimen with traditional Chinese medicine could further improve the clinical efficacy in patients with resistant hypertension with a good safety, but more high-quality clinical studies are still needed to verify this conclusion.

关键词(KeyWords)： 中医药;难治性高血压病;Meta分析
traditional Chinese medicine;resistant hypertension;Meta-analysis

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目(81973824);; 国家中医药管理局中医药循证能力建设项目(2019XZZX-XXG004)

作者(Author): 王梦玺,吴晨洁,曹培华,陈晓虎
WANG Meng-xi,WU Chen-jie,CAO Pei-hua,CHEN Xiao-hu

参考文献(References)：

• [1] LEWINGTON S,CLARKE R,QIZILBASH N,et al.Age-specific relevance of usual blood pressure to vascular mortality:a Meta-analysis of individual data for one million adults in 61 prospective studies[J].Lancet,2002,360(9349):1903.
• [2] WANG Z,CHEN Z,ZHANG L,et al.Status of hypertension in China:results from the China hypertension survey,2012—2015[J].Circulation,2018,137(22):2344.
• [3] WAEBER B,VOLPE M,RUILOPE L M,et al.Diagnosis and treatment of resistant hypertension[J].Blood Press,2014,23:193.
• [4] DAUGHERTY S L,POWERS J D,MAGID D J,et al.Incidence and prognosis of resistant hypertension patients[J].Circulation,2012,125(13):1635.
• [5] 高佳明,吕明,解微微,等.中医药心脑血管疾病同治的方剂用药规律分析[J].中国中药杂志,2019,44(1):193.
• [6] 中华人民共和国卫生部.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
• [7] 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24.
• [8] 高丽君,崔伟锋,范军铭.降压宝系列方药治疗难治性高血压的临床疗效分析[J].中医临床研究,2016,8(30):34.
• [9] 何建平,梁志乐,王小艳.中西医结合治疗老年难治性高血压疗效分析[J].当代医学,2015,21(19):151.
• [10] 贾晓伟,高萍.补肾平肝方内服加浴足治疗肝火亢盛证难治性高血压47例[J].中国实验方剂学杂志,2015,21(12):174.
• [11] 李继彬.自拟天麻川芎汤联合非洛地平及厄贝沙坦氢氯噻嗪治疗老年难治性高血压的效果[J].临床医学研究与实践,2019,4(30):157.
• [12] 曲凡,杨锡燕.五苓散合黄连解毒汤加减治疗难治性高血压的临床效果[J].中国老年学杂志,2020,40(4):692.
• [13] 唐善慈.穴位贴敷治疗难治性高血压疗效观察[J].中西医结合心血管病电子杂志,2019,7(16):193.
• [14] 杨巧红.观察黄芪四物汤加减治疗难治性高血压的临床疗效[J].内蒙古中医药,2014,33(18):36.
• [15] 衣雪锋.豁痰熄风通络方药治疗痰瘀阻络证难治性高血压临床疗效分析[D].长春:长春中医药大学,2015.
• [16] 于俏,吴焕林.邓铁涛沐足方治疗难治性高血压的临床疗效[J].辽宁中医杂志,2019,46(1):79.
• [17] 于俏,吴焕林,吴瑜.温胆汤加减对难治性高血压患者尿微量白蛋白/肌酐的影响[J].中国实验方剂学杂志,2016,22(12):167.
• [18] 于雯.中西药联合治疗难治性高血压30例临床观察[J].临床合理用药杂志,2017,10(13):78.
• [19] 孟醒,熊兴江.初发高血压病、青年高血压病的中医认识及天麻钩藤饮的临床治疗体会[J].中国中药杂志,2020,45(12):2752.
• [20] 熊兴江.葛根芩连汤方证及其在糖尿病、高血压病、高脂血症、肥胖中的运用[J].中国中药杂志,2020,45(12):2760.
• [21] EGAN B M,ZHAO Y,AXON R N,et al.Uncontrolled and apparent treatment resistant hypertension in the US 1988—2008[J].Circulation,2011,124(9):1046.
• [22] SCHMIEDER R E,REDON J,GRASSI G,et al.ESH position paper:renal denervation-an interventional therapy of resistant hypertension[J].J Hypertens,2012,30:837.
• [23] TSIOUFIS C,KORDALIS A,FLESSAS D,et al.Pathophysiology of resistant hypertension:the role of sympathetic nervous system[J].Int J Hypertens,2011,doi:10.4061/2011/642416.
• [24] LAURENT S,SCHLAICH M,ESLER M.New drugs,procedures,and devices for hypertension[J].Lancet,2012,380:591.
• [25] NG F L,SAXENA M,MAHFOUD F,et al.Device-based therapy for hypertension[J].Curr Hypertens Rep,2016,18(8):61.
• [26] BISOGNANO J D,BAKRIS G,NADIM M K,et al.Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension:results from the double-blind,randomized placebo-controlled rheos pivotal trial[J].J Am Coll Cardiol,2011,58(7):765.
• [27] JUDD E K,OPARIL S.Novel strategies for treatment of resistant hypertension[J].Kidney Int Suppl,2013,3:357.
• [28] 张晓丹,杜伟,张晨,等.葛根素对缺氧性肺动脉高压及伴随的肺纤维化的作用[J].中国中药杂志,2018,43(12):2618.
• [29] 李毓扬,吕承豪,吴广,等.铁皮石斛干预代谢综合征的作用分子机制研究进展[J].中国中药杂志,2019,44(23):5102.
• [30] 尹超,徐俞悦,陈国杨,等.铁皮石斛复方对“饮食不节”致高血压大鼠的药效及PI3K/AKT/eNOS信号通路的影响[J].中国中药杂志,2018,43(11):2345.
• [31] 龙红萍,蔺晓源,王宇红,等.基于网络药理学研究复方钩藤降压片治疗高血压的作用机制[J].中国中药杂志,2018,43(7):1360.